Koyfin Home > Directory > Health Care > Amphastar Pharma > Net Debt / EBITDA

Amphastar Pharma Net Debt / EBITDA Chart (AMPH)

Amphastar Pharma annual/quarterly Net Debt / EBITDA from 2003 to 2018. Net Debt / EBITDA is a measure of leverage for a company by dividing the Debt less Cash on hand vs. EBITDA.
  • Amphastar Pharma Net Debt / EBITDA for the quarter ending June 06, 2018 was $0m a -264.29% decrease of -1m year over year
  • Amphastar Pharma Net Debt / EBITDA for the last 12 months ending December 12, 2005 was $4m a -199.81% decrease of -8m year over year
  • Amphastar Pharma Annual Net Debt / EBITDA for 2005 was $4m a -199.81% decrease of -8m from 2004
  • Amphastar Pharma Annual Net Debt / EBITDA for 2003 was $12m
Other Ratios Metrics:
  • Amphastar Pharma Total Debt / Capital for the quarter ending December 12, 2018 was $12m a -1.34% decrease of 0m year over year
  • Amphastar Pharma Other Liabilities for the quarter ending December 12, 2018 was $10m a -0.42% decrease of 0m year over year
  • Amphastar Pharma Total Debt / Equity for the quarter ending December 12, 2018 was $14m a -1.53% decrease of 0m year over year
View Chart On Koyfin

Quarterly AMPH Net Debt / EBITDA Data

06/2018$0m
12/2005$4m
09/2005$8m
06/2005$1m
03/2005$2m
12/2004$3m
03/2004$1m
12/2003$3m

Annual AMPH Net Debt / EBITDA Data

2005$4m
2003$12m